ArticleInternational journal of dermatology2026
Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP-GEP (Merlin) Versus 31-GEP (DecisionDx-Melanoma).
Domenico Bellomo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.